Workshop explores chronic disease prevention
To address the alarming growth of chronic diseases around the world, a group of researchers from all over the globe convened at the Department of Epidemiology and Public Health (EPH) at the School of Medicine May 11-20 to take part in the Community Action to Prevent Chronic Disease (CAPCoD) workshop.
Chronic disease, particularly cardiovascular disease, type 2 diabetes, cancer and chronic respiratory disease account for over 50% of all deaths worldwide. Tobacco use, poor diet and physical inactivity are among the major risk factors contributing to this disease burden.
The workshop was designed to assess promising options for large-scale community intervention research in developing countries and in the United States. Invited participants were principal investigators of 18 potential research projects around the globe and six projects from the United States. These investigators prepared their research proposals based on diverse and innovative approaches to population level interventions to change diet, smoking and physical activity through a variety of strategies.
Lars Rebien Sorensen, president and chief executive officer of the healthcare company Novo Nordisk A/S, delivered a talk titled "Visions for future private-public partnerships."
Describing Novo Nordisk A/S as a world leader in diabetes care, Sorensen cited staggering statistics relating to predictions about the prevalence of diabetes in the future, noting that 370 million people will have diabetes by 2030, with 76% of this total in developing countries.
In response to the crisis, he noted, Novo Nordisk created the World Diabetes Foundation, an independent trust with a goal of creating partnerships with developing countries to assist people with diabetes and to act as a catalyst to help others do more. Sorensen said that a successful approach to combating chronic diseases rests with the combined efforts of the public and private sectors, working in partnership and leveraging each other's strengths. The talk was followed by a roundtable discussion with workshop participants.
During the workshop, the international and U.S. research teams discussed their proposed interventions that plausibly and affordably aim to reduce population burden of chronic diseases in their communities and also exchange their ideas and skills with each other.
"This workshop has opened a new chapter of research and development in chronic diseases all around the world and will help to develop innovative and fundable research projects that will lead to action at the community, national and international level," said Mahmood Adil, director of research & development of CAPCoD projects and visiting scholar from the Department of Health for England.
CAPCoD was initiated by the Oxford Alliance, and is supported by Novo Nordisk A/S, Oxford and Yale. Its projects are based on applied and community-based research, which is needed to assess the effectiveness of the right interventional approaches in different cultures and settings to deal with chronic diseases in an effective and timely manner.
For further information on CAPCoD, contact Adil at (203) 843-7222 or mahmood.adil@yale.edu.
T H I SW E E K ' SS T O R I E S
Yale committed to offering overseas opportunities to all undergraduates
COMMENCEMENT 2005
|